Sinus Mucosal
The sinuses are hollow, bone and mucus lined spaces that lie just to the side of the nose and extend up to the bottom of our skull. There are several different sinuses in the human head and include two large pairedmaxillary (sometimes referred to as cheek sinuses), two frontal and sphenoid sinuses and multiple ethmoid sinuses. Sinus disease occurs in several forms, but all are related to a combination of infection and the inability of air to get into sinus cavities from the nose. Similar to the ear and mastoid, the sinuses are air-filled spaces surrounded by thin bone and lined by mucosa. When the air is absorbed by the mucosa faster than air can get through the sinus openings (ostia) into the sinuses, a relative vacuum develops and fluid is pulled from the lining tissues of the sinuses into the sinus cavities. This fluid easily becomes infected. Allergy causes mucous glands to release thicker fluids (mucous), which can also become infected and which are harder to clean from the sinuses. Sinus disease is not just one entity but many. Overall infectious or inflammatory sinus disease can be broken up into acute (quick onset) or chronic (over a long period of time). Acute sinusitis is the most common form of sinusitis and is typically treated with a combination of antibiotics and agents to decrease inflammation in the nose.
Related Conference of Sinus Mucosal
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Sinus Mucosal Conference Speakers
Recommended Sessions
- Allergic Asthma Treatment and Prevention
- Child Vaccination & Immunization / Pediatric Vaccines
- Mucosa immunization Industries
- Mucosal Diseases
- Mucosal Immunity and Vaccines
- Mucosal Immunology in Urology
- Mucosal Immunology of HIV Infection
- Mucosal Immunology of Host Defenses
- Mucosal Immunology of Infectious Diseases
- Mucosal Immunology of Parasitic Diseases
- Mucosal Melanoma
- Mucosal Vaccination
- Mucosal Vaccines Adjuvants
- Semaphorins as Regulators of Chronic Mucosal Inflammatory Conditions
- Sinus Mucosal
- Vaccine Delivery Systems
- Vaccines Against Infectious Diseases and Cancers
- Veterinary Vaccines
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
